ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 924

Methods to Link a U.S. Arthritis Cohort with Medicare Administrative Claims Data

Jeffrey R. Curtis1, Lang Chen2, Timothy Beukelman3, Aseem Bharat4, Fenglong Xie5, Kenneth G. Saag6 and Elizabeth S. Delzell7, 1Rheumatology & Immunology, Univ of Alabama-Birmingham, Birmingham, AL, 2Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 3Pediatric Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 4Medicine/Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 5Rheumatology & Immunology, University of Alabama at Birmingham, Birmingham, AL, 6Div Clinical Immun & Rheum, Univ of Alabama-Birmingham, Birmingham, AL, 7Epidemiology, University of Alabama at Birmingham, Birmingham, AL

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Claims data and Rheumatoid Arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Epidemiology and Health Services Research: Epidemiology and Outcomes of Rheumatic Disease II

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Linkages between clinical and administrative data may provide a valuable resource for pharmacoepidemiologic and health services research. Objective To describe methods and validity of a linkage between a de-identified national arthritis registry and U.S. Medicare data.

Methods:

Data from 2006-9 for rheumatoid arthritis (RA) patients participating in the Consortium of Rheumatology Researchers of North America (CORRONA) was linked to Medicare (100% sample selected using ICD-9 codes).  Deterministic linkage was performed using age (in years), sex, provider identification number, and U.S. state of the CORRONA site. Medicare data were restricted to rheumatology claims or with an RA diagnosis occurring in CORRONA provider’s state. Visit dates from CORRONA were matched to Medicare visit dates. At least 1 visit date was required to match exactly.

An ‘all-visit match’ was defined when a CORRONA participant had all CORRONA visits match to all Medicare visits. If a CORRONA participant had an all-visit match to >1 Medicare beneficiary, unique matches selected to be the beneficiary with the greatest number of matched CORRONA visits.  In the event of ties, the participant was considered not matched. A fuzzy match was done for CORRONA participants without any all-visit match allowing date mismatches of +- 2 week, or +-1 digit in month, day or year.

Linkage accuracy was evaluated in a sub-cohort with more complete information (including full date of birth [DOB]); exact match on full DOB was used as a gold standard.

Results:

CORRONA participants with self-reported Medicare coverage at any time (n=9326) were identified to be matched to 32,788 Medicare beneficiaries with arthritis treated by CORRONA physicians. A total of 7,441 CORRONA participants matched exactly on at least 1 visit, and 4413 (59%) had an all-visit match to 1 or more beneficiaries; 4013 (54%) were uniquely matched with a median (IQR) of 3 (2, 6) matched visits. For those without any all-visit matches (n=3028), only 346 (11.4%) were able to achieve at least 1 all-visit match after fuzzy matching.

For the 837 participants in the validation subcohort with an all-visit match to a single Medicare beneficiary, match accuracy was 95% for patients with > 2 matched visits, 87% for patients with exactly 2 matched visits, and 73% for those with exactly 1 matched visit. For additional patients who initially matched exactly on at least one but not all visit dates and achieved an all-visit match after fuzzy matching (n=162), linkage accuracy was < 15%. Ongoing work is refining the linkage strategy for resolution of ties and improvement of matching validity and to expand the validation sample

Conclusion:

A novel linkage between a national, de-identified outpatient arthritis registry and U.S. Medicare claims data on multiple non-unique identifiers appears both feasible and valid.


Disclosure:

J. R. Curtis,

Roche/Genetech, UCB, Centocor, CORRONA, Amgen Pfizer, BMS, Crescendo, Abbott,

5,

Roche/Genetech, UCB, Centocor, CORRONA, Amgen Pfizer, BMS, Crescendo, Abbott,

2;

L. Chen,
None;

T. Beukelman,

Pfizer Inc,

2,

Novartis Pharmaceutical Corporation,

5,

Genentech and Biogen IDEC Inc.,

5;

A. Bharat,
None;

F. Xie,
None;

K. G. Saag,
None;

E. S. Delzell,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/methods-to-link-a-u-s-arthritis-cohort-with-medicare-administrative-claims-data/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology